We outline the market outlook for digital biomarkers for vital signs in the pharma and clinical research industry – from investment trends, to leading companies, to recommendations for the players in the space.
What are digital biomarkers for vital signs?
Digital biomarkers for vital signs allow providers to monitor patients in real time and enable pharmaceutical companies to achieve better trial endpoints. Typical variables include body temperature, pulse, respiratory rate, and blood pressure, all of which can help guide treatment decisions.
<![endif]-->
<script charset="utf-8" type="text/javascript" src=https://www.cbinsights.com/research/market-trend-report-digital-biomarkers-vital-signs-pharma-cro-leaders/"//js.hsforms.net/forms/v2.js">
<script>
hbspt.forms.create({
onFormReady: function ($form) {
window.ClearbitForHubspot.addForm($form);
},
region: "na1",
portalId: "763793",
formId: "90955808-0135-4f5d-b9bc-c9c16290b2f4"
});
</script></div></div></div>"}" data-sheets-userformat="{"2":6657,"3":{"1":0},"12":0,"14":{"1":2,"2":4473924},"15":"Arial"}">FREE DOWNLOAD: THE COMPLETE DIGITAL HEALTH 150 LIST
Features & capabilities
Digital biomarkers for vital signs provide pharma and clinical research organization (CRO) leaders with several capabilities, including the following:
- AI-powered, video-based health and wellness monitoring tools
- End-user mobile applications
- Personalized analytics
- Remote patient monitoring and early warning systems
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
